Cladribine tablets for relapsing–remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study
- Resource Type
- Article
- Source
- In
Multiple Sclerosis and Related Disorders January 2012 1(1):49-54 - Subject
- Language
- ISSN
- 2211-0348